Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05703659 · ClinicalTrials.gov registry record · NA
Baby 2 Baby Beneficial Bacteria
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05703659 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 10 participants.
The verdict
NCT05703659, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The investigators will recruit mother-infant dyads to attend weekly lactation support groups and randomize infants to receive either an HMO consuming or non-HMO consuming probiotic. The investigators will collect infant stool before and after support group attendance. The investigators will use qPCR and metagenomic sequencing to test if the study probiotics or other bacteria transmit between infants. The investigators anticipate HMO consuming bacteria will and non-HMO consuming bacteria will not transmit between infants.
Interventions
- DIETARY_SUPPLEMENT B. longum subsp. infantis
- DIETARY_SUPPLEMENT L. reuteri probiotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2025-04-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05703659
The ClinicalTrials.gov registry entry for NCT05703659 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which B. longum subsp. infantis is the first listed.
NCT05703659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05703659 about?
NCT05703659 is a clinical study titled "Baby 2 Baby Beneficial Bacteria". The investigators will recruit mother-infant dyads to attend weekly lactation support groups and randomize infants to receive either an HMO consuming or non-HMO consuming probiotic. The investigators will collect infant stool before and after support group attendance. The investigators will use qPCR...
What is the current status of trial NCT05703659?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2023-03-01. Estimated completion is 2025-04-09.
What interventions are being tested in trial NCT05703659?
The interventions under investigation include: B. longum subsp. infantis (DIETARY_SUPPLEMENT), L. reuteri probiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05703659?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.